![Nisha Nanda](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profilo
Nisha Nanda's former job positions include Senior Director-Clinical Science at Onyx Pharmaceuticals, Inc. from 2012 to 2014, Chief Development Officer at Loxo Oncology, Inc. from 2019 to 2023, and Independent Director at Morphic Holding, Inc. from 2021 to 2024.
Dr. Nanda obtained undergraduate and doctorate degrees from The University of New South Wales.
Precedenti posizioni note di Nisha Nanda
| Società | Posizione | Fine |
|---|---|---|
| MORC HOLD | Direttore/Membro del Consiglio | 16/08/2024 |
| LOXO ONCOLOGY INC | Corporate Officer/Principal | 01/05/2023 |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Corporate Officer/Principal | 01/02/2014 |
Formazione di Nisha Nanda
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
60
Relazioni di 1° grado
4
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Health Technology |
The University of New South Wales
 The University of New South Wales Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Loxo Oncology, Inc.
 Loxo Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops medicine for cancer treatment | Health Technology |
Morphic Holding, Inc.
 Morphic Holding, Inc. Pharmaceuticals: MajorHealth Technology Develops oral integrin drugs | Health Technology |
